 |
WTC Holdings, Ltd. (“WCT”) is a global contract research organization with a focus on early and late stage drug development services for pharmaceutical and biotechnology companies. WCT develops sophisticated and innovative approaches to research, with primary focus in the areas of cardiovascular and central nervous system medicine, along with significant experience in Chronic Inflammatory Disease, Metabolic/Endocrinology and Oncology.
For more information on WCT, visit www.wwctrials.com.